KANATA, Ontario, August 06, 2024--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) has appointed Vittorio Puppo as president of BWXT Medical Ltd., effective August 12, 2024. In his new role ...

With the sale, BWXT now owns Nordion's former medical isotopes business, including the radiochemical and contract manufacturing operations in Kanata, Ontario, and the isotope production facility ...

OTTAWA, Ontario, June 07, 2024--(BUSINESS WIRE)--BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 ...

OTTAWA, Ontario--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug ...

OTTAWA, Ontario--(BUSINESS WIRE)--BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass ...

BWXT subsidiary BWXT Advanced Technologies has finalised its formal cost-sharing contracting with the US Department of Energy for its BANR (BWXT Advanced Nuclear Reactor) transportable microreactor ...

LYNCHBURG, Va. — BWX Technologies, Inc. (NYSE: BWXT) has released its 2023 Sustainability Report, demonstrating the company’s deep involvement in environmental restoration, clean energy ...